Standard versus extended dual antiplatelet therapy after pci in acute coronary syndrome: a systematic review and meta-analysis
The absence of benefit was confirmed both during overall follow-up and in landmark 12-month analyses, with a reduction observed only in repeat revascularisation, a softer endpoint, and findings support an individualised approach to DAPT duration rather than routine prolongation beyond one year.